David H. Johnson
0000-0001-6851-6888
Publication & Citation Trends
Most Cited Works
Publications
382 total
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Cited by 299
OpenAlex
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Cited by 451
OpenAlex
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Cited by 646
OpenAlex
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Cited by 849
OpenAlex
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer PDF
Cited by 313
OpenAlex
Non–Small Cell Lung Cancer PDF
Cited by 734
OpenAlex
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Cited by 3,003
OpenAlex
Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599 PDF
Cited by 350
OpenAlex
Research Topics
Lung Cancer Research Studies
(88)
Lung Cancer Treatments and Mutations
(68)
Neuroendocrine Tumor Research Advances
(60)
Cancer therapeutics and mechanisms
(32)
Cancer Treatment and Pharmacology
(30)
Frequent Co-Authors
Affiliations
Millersville University
Medical Council of Canada
Northwestern University
University of North Carolina at Chapel Hill
University of Southern California